CAFC Reverses PTAB Decision that Invalidated Sanofi Injector Pen Patent
Briefly

"In evaluating whether a reference is analogous, we have consistently held that a patent challenger must compare the reference to the challenged patent."- CAFC
The U.S. Court of Appeals for the Federal Circuit (CAFC) issued a precedential decision Tuesday that reversed a Patent Trial and Appeal Board (PTAB) decision invalidating claims of Sanofi's U.S. Patent No. RE47,614, which covers a drug delivery device.
Read at IPWatchdog.com | Patents & Intellectual Property Law
[
add
]
[
|
|
]